Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
R John Fletcher is Director at Koru Medical Systems. OQRO lists 5 transactions filed with the SEC under this name, the latest on Oct 2, 2026, each linked to the official Form 4.
Director
Disclosures on record
5
Companies involved
2
As of the latest filing on , R John Fletcher reported holding 132,004 shares of Clearpoint Neuro (CLPT), worth about $1.12M at the last close of $8 (Nov 13, 2026). Holdings are also on file at Koru Medical Systems (KRMD); together they are worth about $2.01M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Clearpoint Neuro CLPT | 132,004 | 132K direct | $8 | $1.12M | Oct 1, 2026 |
| Koru Medical Systems KRMD | 239,836 | 240K direct | $4 | $887K | Oct 1, 2026 |
Is this R John Fletcher’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Clearpoint NeuroCLPT
Oct 1, 2026993disclosed Oct 2
DetailsOfficial recordKoru Medical SystemsKRMD
4 disclosures · Jan 2026 – Oct 2026
Oct 1, 20267,679
DetailsOfficial recordJul 1, 20265,357
DetailsOfficial recordApr 1, 20265,208
DetailsOfficial recordJan 2, 20263,872
DetailsOfficial recordR John Fletcher bought shares on the open market in 7 different years since 2007, and has not bought since 2021 across 2 companies. Sales in 3 of the 20 years since 2007.
R John Fletcher reported 8 open-market purchases and 6 sales since 2007; purchases in 7 different years, most recently 2021.
| Year | Bought | Sold |
|---|---|---|
| 2021 | $108K1×1 trade | $268K1×1 trade |
| 2020 | $100K2×2 trades | $1.35M1×1 trade |
| 2019 | — | $1.44M4×4 trades |
| 2014 | $8.7K1×1 trade | — |
| 2013 | $18K1×1 trade | — |
| 2012 | $5.2K1×1 trade | — |
| 2011 | $29K1×1 trade | — |
| 2007 | $49K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Oct 1, 2026, R John Fletcher reported holding 132,004 shares of Clearpoint Neuro (CLPT). At the last close of $8 on Nov 13, 2026, that is about $1.12M. This is the stake disclosed in filings, not a net worth.
R John Fletcher bought shares on the open market in 7 different years since 2007, and has not bought since 2021 across 2 companies. Sales in 3 of the 20 years since 2007.
In SEC filings since 2007: the latest open-market purchase is from 2021; the latest open-market sale is from 2021.
2 companies: Axcelis Technologies, Inc. (ACLS, 2007–2021), Koru Medical Systems (KRMD, 2020–2021).
R John Fletcher reported 5 open-market purchases and 6 sales here, 2007 to 2021.
R John Fletcher reported 3 open-market purchases and 0 sales here, 2020 to 2021.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
